Skip to main content

Find Clinical Trials

Home
Conditions
Clear-cell metastatic renal cell carcinoma

Clinical trial condition

Clear-cell metastatic renal cell carcinoma

Explore clinical trials studying Clear-cell metastatic renal cell carcinoma. Study availability and eligibility vary by location and protocol.

54 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Clear-cell metastatic renal cell carcinoma trial results

Not yet recruiting

Phase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal Cell Carcinoma

NCT07828249

Conditions: Clear-cell metastatic renal cell carcinoma, Metastatic Clear Cell Renal Cell Carcinoma
Locations: Centre Léon Bérard Lyon, France

View Trial Details

Not yet recruiting

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

NCT07576725

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
Locations: Uganda Cancer Institute Kampala, Uganda

View Trial Details

Not yet recruiting

TACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell Carcinoma

NCT07776717

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +19 more
Locations: Not specified

View Trial Details

Not yet recruiting

Imaging Study in Metastatic Clear Cell RCC.

NCT07671417

Conditions: Clear-cell metastatic renal cell carcinoma, Metastatic Clear Cell Renal Cell Carcinoma
Locations: Research Facility Christchurch, New Zealand

View Trial Details

Not yet recruiting

Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

NCT07578025

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Not yet recruiting

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

NCT07218692

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, +23 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Not yet recruiting

Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

NCT06279403

Conditions: Clear-cell Metastatic Renal Cell Carcinoma, Clear-cell metastatic renal cell carcinoma, Cytoreductive Nephrectomy, +1 more
Locations: Not specified

View Trial Details

Not yet recruiting

Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours

NCT05698238

Conditions: Adenoma, Breast Diseases, Breast Neoplasms, +25 more
Locations: Not specified

View Trial Details

Enrolling by invitation

Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

NCT07488572

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, not recruiting

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

NCT05012371

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +18 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

M D Anderson Cancer Center Houston, Texas, United States

University of Virginia Charlottesville, Virginia, United States

View Trial Details